2008-05-05 10:04:03 -

www.researchandmarkets.com - Research and Markets (www.researchandmarkets.com/reports/c90797) has announced the addition of "Pulmonary Arterial Hypertension: Diagnosis and Evidence-Based Treatment" to their offering.

First book dedicated to this disease, previously thought to be incurable, but with the advent of new drugs, now amenable to management and a much improved prognosis for patients

From the

PAH Association, the leading experts in field

Incorporates the latest AACP management guidelines

Includes evidence-based treatment algorithms based on the recently updated ACCP Guidelines for Medical Treatment

Aimed at specialists in pulmonology and cardiovascular disease, this volume provides the clinician with the most up to date information on the effective management of PAH

Key topics:

- Introduction

- Diagnosis and assessment of pulmonary arterial hypertension

- Conventional therapy in pulmonary arterial hypertension

- Prostanoid treatment for pulmonary arterial hypertension

- Endothelin receptor antagonists in pulmonary arterial

- Phosphodiesterase-5 inhibitors in pulmonary arterial hypertension

- Combination therapy for pulmonary arterial hypertension

- Interventional and surgical modalities of treatment for pulmonary arterial hypertension

- End points and clinical trial design in pulmonary arterial hypertension: Clinical and regulatory perspectives

- Comparative analysis of clinical trials and evidence-based treatment algorithm for pulmonary arterial hypertension

- Diagnosis and assessment of non-pulmonary arterial hypertension masquerading as idiopathic pulmonary arterial hypertension: Diastolic heart failure - evaluation and interactions

- Treatment of pulmonary arterial hypertension: A look to the future

For more information visit www.researchandmarkets.com/reports/c90797

Research and Markets
Laura Wood
Senior Manager
Fax: +353 1 4100 980
press@researchandmarkets.com